Approval · Notice of Compliance 33582 · 2024
ALEVE CAPLETS: Notice of Compliance 33582
Issued July 5, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33582
- Date
- July 5, 2024
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate Drug Product Manufacturer, Change in drug product manufacturing process, Change in the composition
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALEVE CAPLETS | Not yet assigned | — |
Medicinal ingredients
- NAPROXEN SODIUM 220 MG per TAB